The rising prevalence of chronic diseases such as cancer, HIV/AIDS, and autoimmune diseases is a major driver for the flow cytometry market. Flow cytometry is a vital tool for analyzing cells and their properties, widely used in research and clinical settings for diagnosing, monitoring, and treating various diseases. As the demand for more advanced and complex flow cytometry technologies increases, companies are investing in research and development to develop innovative products that better meet the needs of researchers and clinicians. This trend is expected to drive rapid growth in the market as it continues to address the evolving diagnostic needs of chronic diseases.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-flow-cytometry-market
Data Bridge Market Research analyses that the Global Flow Cytometry Market is expected to reach USD 13.73 billion by 2031 from USD 5.78 billion in 2023 growing with a CAGR of 11.5% in the forecast period of 2024 to 2031.
Key Findings of the Study
Increase in Use of Flow Cytometry in Drug Discovery
The expansion of research activities is a key driver for the growth of the global flow cytometry market, particularly in drug discovery and development. Flow cytometry's ability to analyze heterogeneous cell populations provides a promising avenue for exploring drug discovery processes. It offers high-resolution insights into single-cell multiparameter functional and biological information, enhancing the efficiency of finding and characterizing novel bioactive medicines. Advancements in flow cytometry approaches, such as high-throughput multifactorial analysis, cell sorting improvements, and quick event detection and resolution, further contribute to its effectiveness in drug discovery. In addition, the development of flow cytometry bead array technologies has opened up new research avenues, providing insights into various biomarkers and cellular mechanisms, thus adding value to flow cytometry's role in drug discovery and development.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion
|
|
Segments Covered
|
By Product (Reagents and Consumables, Flow Cytometry Instruments, Accessories, Services, and Software), Technology (Cell-Based Flow Cytometry and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End User (Pharmaceuticals & Biotechnology Companies, Academic & Research Institutes, Hospitals, Clinical Testing Laboratories, Blood Bank, and Others), Distribution Channel (Retail Sales and Direct Tenders)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Netherland, Switzerland, Turkey, Belgium, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt and rest of Middle East and Africa
|
|
Market Players Covered
|
Sysmex Corporation (Japan), Agilent Technologies, Inc. (U.S.), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Sony Biotechnology Inc. (U.S), Apogee Flow Systems Ltd. (U.K.), Cytek Biosciences (U.S.), BIOMÉRIEUX (France), Merck KGaA (Germany), Elabscience Bionovation Inc. (U.S.), Miltenyi Biotec (Germany), Takara Bio Inc. (Japan), Thermo Fisher Scientific Inc. (U.S.), Q2 Solutions (U.S.), CellKraft Biotech Pvt. Ltd. (India), Sartorius AG (Germany), NeoGenomics Laboratories (U.S.), Cell Signaling Technology, Inc. (U.S), CytoBuoy (Netherland), ORFLO Technologies (U.S.), IKEDA SCIENTIFIC Co., Ltd. (Japan), BioLegend, Inc. (U.S.), Cohorent Corp. (U.S.), Union Biometrica, Inc. (U.S.), Cytonome/ST, LLC (U.S.), Stratedigm, Inc (U.S.), NanoCellect Biomedical (U.S.), BennuBio Inc., (U.S), Nexcelom Bioscience LLC (U.S.), On-chip Biotechnologies Co., Ltd. Corporation (Japan), and Enzo Biochem Inc (U.S.), among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
Segment Analysis
The global flow cytometry market is segmented into five notable segments based on product, technology, application, end user, and distribution channel.
- On the basis of product, the global flow cytometry market is segmented into flow cytometry instruments, reagents and consumables, software, accessories, and services
In 2024, reagents and consumables segment is expected to dominate the global flow cytometry market
In 2024, reagents and consumables segment is expected to dominate the global flow cytometry market with 58.21% market share due to rising technological advancement and its wide use in research by academic and research institutes, pharmaceuticals, and biotechnology companies.
- On the basis of technology, the global flow cytometry market is segmented into cell-based flow cytometry and bead-based flow cytometry
In 2024, cell-based flow cytometry segment is expected to dominate the global flow cytometry market
In 2024, cell-based flow cytometry segment is expected to dominate the global flow cytometry market with a 63.39% market share due to rising technological advancement and its wide use in research by academic and research institutes.
- On the basis of application, the global flow cytometry market is segmented into research applications, clinical applications, and industrial applications. In 2024, the research applications segment is expected to dominate the market with a 54.79% market share
- On the basis of end user, the global flow cytometry market is segmented into academic & research institutes, hospitals, pharmaceutical & biotechnology companies, clinical testing laboratories, blood bank, and others. In 2024, the pharmaceutical & biotechnology segment is expected to dominate the market with a 36.08% market share
- On the basis of the distribution channel, the global flow cytometry market is segmented into direct tenders and retail sales. In 2024, the retail sales segment is expected to dominate the market with a 55.51% market share
Major Players
Data Bridge Market Research analyzes Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), BD (U.S.), Sartorius AG (Germany), Sysmex Corporation (Japan) as the major companies operating in the global flow cytometry market.
Market Developments
- In February 2023, Cytek Biosciences, Inc. announced that Luminex Corporation, a wholly owned subsidiary of DiaSorin, has entered into an agreement with Cytek to sell substantially all of its assets related to its FCI business unit. The sale is expected to close within 30 days, subject to customary closing conditions. The current installed base of more than 7,000 instruments will remain under the Cytek umbrella following the acquisition, which will increase the company's global business footprint
- In February 2023, Agilent Technologies Inc. announced the release of new NovoExpress software that introduces integrated compatibility tools for NovoCyte flow cytometry systems. These software features allow users to meet regulatory requirements as defined in FDA 21 CFR Part 11 and Appendix 11
- In August 2022, NanoCellect Biomedical announced that it had received a $1.8 million Phase II Small Business Innovation Research (SBIR) grant from the National Institutes of Health. General Medical Sciences continues to develop imaging flow cytometry technology for cell sorting based on AI characteristics. This grant extends NanoCellect's successful research programs to develop new imaging flow cytometry technology and expands an ongoing multi-year research collaboration between the University of California, San Diego (UCSD) and NanoCellect to advance single-cell analysis techniques
- In March 2022, Beckman Coulter, Inc. launched a powerful solution to manual sample preparation and data management bottlenecks in clinical flow cytometry: The CellMek SPS. The product is a fully automated sample preparation system (SPS) that offers on-demand processing for a multitude of sample types to help laboratories to expand their capabilities. This thereby enhanced company's flow cytometry portfolio
- In February 2022, the company was presented with the prestigious Ignite award at the Society for Laboratory Automation and Screening (SLAS) Annual International Conference and Exhibition. The Innovation AveNEW area of the SLAS International Conference and Exhibition, which is specifically reserved for start-ups and emerging firms, is where the SLAS Ignite Award is given to the finest start-up or emerging company exhibiting there. This helped company in gaining more recognition
Regional Analysis
Geographically, the countries covered in the global flow cytometry market report are U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Netherland, Switzerland, Turkey, Belgium, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt and rest of Middle East and Africa.
As per Data Bridge Market Research analysis:
North America is expected to dominate and be the fastest growing region in the global flow cytometry market
North America is expected to dominate global flow cytometry market due to its high level of technological advancement. The region boasts a strong presence of market players who continually invest in research and development to develop innovative products. This technological advancement has enabled North America to address the evolving diagnostic needs of chronic diseases effectively. The region's focus on expanding research activities, particularly in drug discovery and development, has further propelled its dominance in the global flow cytometry market.
For more detailed information about global flow cytometry market report, click here – https://www.databridgemarketresearch.com/reports/global-flow-cytometry-market
